Zh Nevrol Psikhiatr
-
Zh Nevrol Psikhiatr · Jan 2011
[Mental health of the world population: epidemiological aspects (the analysis of foreign research results for 2000-2010)].
Modern approaches to studying prevalence of a mental pathology and the results received during 2000-2010 are analyzed according to a condition of mental health of the population of separate regions and countries of the world. Information sources were databases of the WHO, a database of the United States National Library of Medicine "PubMed", archives of publications of leading foreign medical magazines in the field of mental health. The growth of prevalence and incidence of mental illnesses, especially depressive and anxiety disorders, with the corresponding increasing burden of mental disorders worldwide is observed. To obtain reliable results, modern schemes of epidemiological studies should be realized with the account of social-cultural level of the population, adaptation of diagnostic tools, qualitative preparation and training of the personnel and with the precise use of statistical criteria and requirements to the selection and analysis of research information.
-
Zh Nevrol Psikhiatr · Jan 2011
[The retrospective study of efficacy and safety of levetiracetam as an add-on treatment of epilepsy in children].
The objective was to retrospectively study the efficacy and safety of levetiracetam (keppra) as an add-on treatment of pharmacoresistant forms of epilepsy in children. We have analyzed medical histories of 192 patients with pharmacoresistant epilepsy admitted to a neurological department of the Research and Treatment Center of Children's Medical Care over the period of 2008-2011. The patient's age varied in the range from 6 months to 19 years (mean age 5.7 years). ⋯ Levetiracetam is well tolerated in the children age. Side-effects that were not life threatening were noted only in 6.2% of patients and the retention rate was 75.5%. The aggravation of seizures and EEG abnormalities, regardless of the epilepsy form, type of seizure, drug dose or the combination of anticonvulsants were seen in 5.7% of patients.